Bora Pharmaceuticals Co., LTD. (TPE:6472)

TPE:6472 Balance Sheet

Financials in millions TWD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	4,310	5,829	3,053	3,281	910.75	669.99
Short-Term Investments	35.83	67.86	342.63	247.62	-	-
Trading Asset Securities	20.28	20.28	-	-	-	-
Cash & Short-Term Investments	4,366	5,917	3,396	3,529	910.75	669.99
Cash Growth	-42.42%	74.25%	-3.77%	287.48%	35.94%	23.46%
Accounts Receivable	8,100	10,482	4,028	6,120	824.77	539.63
Other Receivables	361.24	954.57	82.61	286.38	33.23	186.77
Receivables	8,461	11,436	4,111	6,407	858.01	726.4
Inventory	3,225	5,502	2,157	1,991	928.64	1,112
Prepaid Expenses	554.22	591	801.43	242.47	63.07	51.33
Other Current Assets	1,177	118.63	138.63	71.58	31.87	67.01
Total Current Assets	17,783	23,566	10,604	12,241	2,792	2,627
Property, Plant & Equipment	10,723	12,510	7,494	7,300	4,067	4,158
Long-Term Investments	4,882	236.33	21.26	62.03	-	-
Goodwill	2,665	3,664	3,010	983.59	-	-
Other Intangible Assets	3,543	3,780	2,665	1,164	171.05	4.93
Long-Term Deferred Tax Assets	1,641	1,190	1,045	829.64	243.78	37.09
Other Long-Term Assets	726.98	652.74	294.85	181.01	98.65	177.22
Total Assets	41,964	45,599	25,134	22,761	7,372	7,004
Accounts Payable	855.25	792.34	380.45	454.74	235.81	219.06
Accrued Expenses	129.51	132.63	30.86	29.33	321.24	217.8
Short-Term Debt	1,934	2,598	767.51	2,161	645.48	1,218
Current Portion of Long-Term Debt	1,622	1,189	630.5	725.63	222.09	161.65
Current Portion of Leases	90.09	116.6	106.04	75.31	17.54	18.68
Current Income Taxes Payable	363.62	484.33	987.43	238.65	50.58	18.35
Current Unearned Revenue	238.58	245.6	224.6	85.69	20.47	4.11
Other Current Liabilities	7,041	8,250	5,102	6,725	327.91	428.77
Total Current Liabilities	12,273	13,809	8,229	10,496	1,841	2,286
Long-Term Debt	13,370	14,324	2,724	4,037	1,028	1,158
Long-Term Leases	739.65	745.96	763.33	596.88	305.97	325.37
Long-Term Unearned Revenue	26.07	-	-	4.18	-	-
Long-Term Deferred Tax Liabilities	1,132	1,256	783.9	742.85	609.77	202.01
Other Long-Term Liabilities	257.85	323.59	753.09	1,608	298.57	413.15
Total Liabilities	27,896	30,587	13,368	17,621	4,220	4,539
Common Stock	1,037	1,031	1,014	753.82	684.12	541.15
Additional Paid-In Capital	4,579	4,408	3,318	1,236	1,026	951.65
Retained Earnings	7,381	7,107	4,729	2,549	1,466	961.01
Treasury Stock	-64.65	-43.18	-50.97	-53.09	-	-
Comprehensive Income & Other	-936.02	364.58	74.66	42.2	-23.26	10.95
Total Common Equity	11,996	12,867	9,085	4,528	3,153	2,465
Minority Interest	2,072	2,144	2,681	612.13	-	-
Shareholders' Equity	14,068	15,012	11,766	5,140	3,153	2,465
Total Liabilities & Equity	41,964	45,599	25,134	22,761	7,372	7,004
Total Debt	17,755	18,973	4,991	7,596	2,219	2,881
Net Cash (Debt)	-13,389	-13,056	-1,595	-4,067	-1,308	-2,211
Net Cash Per Share	-96.62	-97.14	-12.84	-34.34	-11.20	-19.10
Filing Date Shares Outstanding	103.45	123.39	121.33	117.01	117.32	115.68
Total Common Shares Outstanding	103.45	123.39	121.33	117.01	117.32	115.68
Working Capital	5,510	9,757	2,375	1,745	951.22	340.48
Book Value Per Share	115.96	104.28	74.88	38.70	26.87	21.31
Tangible Book Value	5,788	5,423	3,410	2,381	2,981	2,460
Tangible Book Value Per Share	55.95	43.95	28.10	20.35	25.41	21.26
Land	3,658	3,824	3,424	3,397	1,984	2,021
Buildings	7,056	7,963	1,945	1,905	1,393	1,329
Machinery	4,764	6,113	2,814	2,390	859.79	838.14
Construction In Progress	609.24	527.38	115.84	76.72	11.73	-
Leasehold Improvements	-	-	-	205.29	-	8.1

Source: S&P Global Market Intelligence. Standard template. Financial Sources.